Tech Company Financing Transactions

Neurogastrx Funding Round

Neurogastrx closed a $60 million Series B funding round on 8/27/2021. Backers included Vivo Capital, 5AM Ventures and private investors.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

600 Unicorn Park Dr.
Woburn, MA 01801
USA

Phone

Undisclosed

Website

www.neurogastrx.com

Email Address

[email protected]

Overview

Neurogastrx, Inc. is a biopharmaceutical company developing products for the treatment of gastrointestinal disorders.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

James O'Mara

        

Chief Scientific Officer

Cyril De Colle

        

Browse more venture capital transactions:

Prev: 8/27/2021: PicsArt venture capital transaction
Next: 8/27/2021: Oomnitza venture capital transaction

Share this article

Where The Data Comes From

We report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary